{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Episode 192 - Tom Krohn","description":"Tom Krohn is the Chief Development Officer at Antidote. In this episode, Tom details a collaboration between phaware global association\u00ae and Antidote Technologies to accelerate  lung disease research. This  partnership provides pharmaceutical companies with end-to-end clinical trial recruitment services through an extensive network of patients with chronic lung diseases. Tom is an experienced executive leader in multiple healthcare and IT settings including sub-Saharan Africa development, US hospital and retail pharmacies, and the pharmaceutical industry. He has a personal passion and commitment to use his talents to serve the marginalized of society. Learn more about pulmonary hypertension trials at www.phaware.global\/clinicaltrials. Never miss an episode with the phaware\u00ae podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube &amp;amp; Linkedin Engage for a cure: www.phaware.global\/donate #phaware&amp;nbsp;@antidote_me @accpchest&amp;nbsp; ","author_name":"I'm Aware That I'm Rare: the phaware\u00ae podcast","author_url":"http:\/\/phawarepodcast.libsyn.com\/podcast","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/7049162\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/87A93A\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/23304912"}